Sign In
Buy BNTX
$88.45
-0.690 (-0.774%)
At Close: Jun 03, 2026
New Strong Buy Stocks for July 11th
09:32am, Tuesday, 11'th Jul 2023
BLBD, BNTX, EC, TIMB and HIVE have been added to the Zacks Rank #1 (Strong Buy) List on July 11, 2023.
Pfizer/BioNTech initiate application with EU regulator for updated COVID vaccine
05:19pm, Friday, 23'rd Jun 2023
Pfizer and partner BioNTech said on Friday they have initiated an application to the European Medicines Agency (EMA) for authorization of updated COVID-19 vaccine targeting Omicron subvariant XBB.1.5.
BioNTech: Navigating Post-Pandemic Challenges With Innovative Therapies And Bold Strategies
08:43am, Sunday, 18'th Jun 2023
BioNTech's Q1 2023 revenues decreased to $1,404.7 million due to a drop in global COVID-19 vaccine sales, but the company has a strong immunotherapy pipeline for future growth. The company's financial
FDA Panel Endorses Updating COVID Jab to Target XBB Strain
01:05pm, Friday, 16'th Jun 2023
An FDA panel unanimously recommends updating COVID vaccines to target one of the currently dominating XBB strains of the virus.
BioNTech vaccine hearing postponed after complaint over bias
04:42am, Monday, 12'th Jun 2023
The first hearing in a German court case against BioNTech over alleged side effects of its COVID-19 vaccine was postponed by a court on Monday.
BioNTech faces first German lawsuit over alleged COVID vaccine side effects
05:56am, Sunday, 11'th Jun 2023
BioNTech will go to court on Monday to defend itself against a lawsuit from a German woman who is seeking damages for alleged side effects of its COVID-19 vaccine, the first of potentially hundreds of
3 Ugly Stocks That Actually Hide Beautiful Potential
08:17pm, Monday, 05'th Jun 2023
While the market theoretically prices in all publicly available information for all securities, the sheer volume of opportunities available breathe life into underrated stocks with potential. Put anot
BioNTech (BNTX) Up on Initial Data From Lung Cancer Antibody
01:56pm, Monday, 05'th Jun 2023
BioNTech (BNTX) announces positive initial data evaluating BNT316/ONC-392 to treat metastatic non-small cell lung cancer.
Why Shares of BioNTech Rose Friday
04:37pm, Friday, 02'nd Jun 2023
BioNTech's shares have fallen this year, along with its revenue. The company said it expects $5 billion in 2023 revenue from its COVID-19 vaccine, Comirnaty.
BioNTech Surges On This Promising Update In Its Bid To Take On Bristol Myers In Lung Cancer Treatment
11:11am, Friday, 02'nd Jun 2023
BioNTech said Friday almost a third of patients with a hard-to-treat form of lung cancer responded to its treatment — and BNTX stock popped.
BioNTech says drug from OncoC4 partnership shows promise in mid-stage trial
06:48am, Friday, 02'nd Jun 2023
BioNTech said on Friday that a new cancer immunotherapy candidate that it is working on with U.S. partner OncoC4 Inc was shown to shrink tumours in close to 30% of participants in a mid-stage lung can
7 Deeply Undervalued Growth Stocks to Buy in June
08:04pm, Thursday, 01'st Jun 2023
Typically, securities may be less appreciated by the market because they stink, which means several proposals for best undervalued growth stocks for June might not make the cut. At the same time, bett
BioNTech is proceeding with COVID-shot in line with WHO guidance
08:47am, Thursday, 25'th May 2023
Germany's BioNTech said it was on track to introduce a COVID-19 shot by the early fall in the northern hemisphere that is adapted to currently dominant virus variants in line with recommendations by t
Report of new COVID wave in China pushes shares of vaccine makers higher
05:32pm, Tuesday, 23'rd May 2023
Dr. Kavita Patel, fmr. White House health policy director, joins 'Fast Money' to discuss the latest reports of a possible uptick of COVID cases in China, the immunity situation in the country, and the
2 Undervalued Stocks to Buy for Potentially Massive Gains in the Next 10 Years
08:20am, Tuesday, 23'rd May 2023
Certain biotechs that hit it big early during the pandemic are now undervalued. BioNTech is preparing for a rapid pace of new drug launches.
